Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?
Center for Biologics Evaluation and Research.
L E
LE
Black
J D
JD
Green
J
J
Rener
A
A
Dayan
J A
JA
Cavagnaro
P
P
Spindler
J L
JL
Bussiere
P
P
Bouchard
T
T
Inoue
P T
PT
Thomas
D M
DM
Essayan
N A
NA
Gillett
T K
TK
Hart
K
K
Hastings
R V
RV
House
D
D
Latta
U
U
Liminga
G
G
Treacy
D
D
Wierda
D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000633:toxicity*; D001702:Biopharmaceutics; D004353:Drug Evaluation, Preclinical
D000276:Adjuvants, Immunologic